These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Economic costs of functional dyspepsia. Nyrén O; Lindberg G; Lindström E; Marké LA ; Seensalu R Pharmacoeconomics; 1992 May; 1(5):312-24. PubMed ID: 10146996 [TBL] [Abstract][Full Text] [Related]
3. Cost-effective management of dyspepsia and gastroesophageal reflux disease. Steele GH Prim Care; 1996 Sep; 23(3):561-76. PubMed ID: 8888345 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches. Sonnenberg A; Townsend WF; Müller AD Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):655-9. PubMed ID: 8590161 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting. Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. Chey WD; Fendrick AM Arch Intern Med; 2001 Sep; 161(17):2129-32. PubMed ID: 11570943 [TBL] [Abstract][Full Text] [Related]
7. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Rezailashkajani M; Roshandel D; Shafaee S; Zali MR Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588 [TBL] [Abstract][Full Text] [Related]
8. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Kalish SC; Bohn RL; Avorn J Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201 [TBL] [Abstract][Full Text] [Related]
9. Economic analysis of treatment of functional dyspepsia. An assessment of the quality of published studies. García-Altés A; Jovell E Int J Technol Assess Health Care; 2001; 17(4):517-27. PubMed ID: 11758296 [TBL] [Abstract][Full Text] [Related]
10. The Omega-Project--a comparison of two diagnostic strategies for risk- and cost-oriented management of dyspepsia. Brignoli R; Watkins P; Halter F Eur J Gastroenterol Hepatol; 1997 Apr; 9(4):337-43. PubMed ID: 9160195 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of dyspepsia. A cost-effectiveness analysis. Read L; Pass TM; Komaroff AL Med Decis Making; 1982; 2(4):415-38. PubMed ID: 6820678 [TBL] [Abstract][Full Text] [Related]
18. Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia. Fauli S; Thue G Eur J Health Econ; 2008 Aug; 9(3):221-8. PubMed ID: 17570004 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic and therapeutic algorithm in functional dyspepsia]. Iantorno G; Corti R; Fernández LM; Soifer L; Bilder C; Soifer G; De Los Santos AR; Gianoni C; Bernstein S; Secilio O Acta Gastroenterol Latinoam; 2007 Sep; 37 Suppl 1():S25-8. PubMed ID: 18274058 [TBL] [Abstract][Full Text] [Related]
20. Influence of organic and functional dyspepsia on work productivity: the HEROES-DIP study. Sander GB; Mazzoleni LE; Francesconi CF; Balbinotto G; Mazzoleni F; Wortmann AC; Cardoso Ide Q; Klamt AL; Milbradt TC; Value Health; 2011; 14(5 Suppl 1):S126-9. PubMed ID: 21839884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]